Effects of von Willebrand factor concentration and platelet collision on shear-induced platelet activation

Thrombosis and Haemostasis

Volumn 100, Issue 1, 2008, Pages 60-69

  Gao, Zhenyue ^a   Liu, Fang ^b   Yu, Ziqiang ^b   Bai, Xia ^b   Yang, Chun ^a   Zhuang, Fengyuan ^a   Ruan, Changgeng ^b  

^a BEIHANG UNIVERSITY   (China)

^b Jiangsu Institute of Hematology   (China)

Author keywords

Cone plate viscometer; Flow chamber; Platelet collision; SIPA(ct); vWF

Indexed keywords

LIPOCORTIN 5; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ARTICLE; FLOW CYTOMETRY; FLOW MEASUREMENT; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SHEAR FLOW; SHEAR STRESS; THROMBOCYTE ACTIVATION; VISCOMETER;

ANNEXIN A5; BLOOD PLATELETS; CONSTRICTION, PATHOLOGIC; FLOW CYTOMETRY; HEMORHEOLOGY; HUMANS; MEMBRANE PROTEINS; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; PULSATILE FLOW; STRESS, MECHANICAL; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 46749156227     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-03-0222     Document Type: Article

References (50)

1. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297.
2. Kroll MH, Hellums JD, McIntire LV, et al. Platelets and shear stress. Blood 1996; 88: 1525-1541.
3. Ikeda Y, Murata M, Goto S. Von Willebrand factor-dependent shear-induced platelet aggregation: basic mechanisms and clinical implications. Ann NY Acad Sci 1997; 811: 325-336.
4. Shankaran H, Alexandridis P, Neelamegham S. Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood 2003; 101: 2637-2645.
5. IkedaY, Handa M, Kamata T, et al. Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Thromb Haemost 1993; 69: 496-502.
6. O'Brien JR, Salmon GP. Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's disease. Blood 1987; 70: 1354-1361.
7. Peterson DM, Stathopoulos NA, Giorgio TD, et al. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 1987; 69: 625-628.
8. Andrew DB. Plasma von Willebrand factor, thrombosis, and the endothelium: The first 30 years. Thromb Haemost 2006; 95: 49-55.
9. Ruggeri ZM. von Willebrand factor. J Clin Invest 1997; 99: 559-563.
10. Sadler JE. Biochemistry and genetics of von Willebrand factor. Ann Rev Biochem 1998; 67: 395-424.
11. Ruggeri ZM. von Willebrand factor and the mechanisms of platelet function. Springer; 1998.
12. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297.
13. James KH, Robert ES, Gwen AM, et al. Pharmacologic inhibition of platelet vWF-GPIbα interaction prevents coronary artery thrombosis. Thromb Haemost 2006; 95: 469-475.
14. Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature 1979; 279: 636-638.
15. Schoenwaelder SM, Hughan SC, Boniface K, et al. RhoA sustains integrin αIIbβ3 adhesion contacts under high shear. J Biol Chem 2002; 277: 14738-14746.
16. 2+-calmodulin and myosin light chain kinase activation. J Biol Chem 2004; 279: 26266-26273.
17. Belval TK, Hellums JD. Analysis of shear-induced platelet aggregation with population balance mathematics. Biophys J 1986; 50: 479-487.
18. Holme PA, Ørvim U, Hamers MJAG, et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997; 17: 646-653.
19. Goto S, Ikeda Y, Saldívar E, et al. Distinct Mechanisms of Platelet Aggregation as a Consequence of Different Shearing Flow Conditions. J Clin Invest 1998; 101: 479-486.
20. Depraetere H, Ajzenberg N, Girma JP, et al. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor. Blood 1998; 91: 3792-3799.
21. Pontiggia L, Steiner B, Ulrichts H, et al. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIbα. Thromb Haemost 2006; 96: 774-780.
22. Wang JS. Intense exercise increases shear-induced platelet aggregation in men through enhancement of von Willbrand factor binding, glycoprotein IIb/IIIa activation, and P-selectin expression on platelets. Eur J Appl Physiol 2004; 91: 741-747.
23. van Mourik JA, Mochtar IA. Purification of human antihemophilic factor (factor VIII) by gel chromatography. Biochim Biophys Acta 1970; 221: 677-679.
24. Ruan CG, Du XP, Xi XD, et al. A murine antiglycoprotein Ib complex monoclonal antibody, SZ2, inhibits platelet aggregation induced by both ristocetin and collagen. Blood 1987; 69: 570-577.
25. Kasirer-Friede A, Cozzi MR, Mazzucato M, et al. Signaling through GP Ib-IX-V activates αIIbβ3 independently of other receptors. Blood 2004; 103: 3403-3411.
26. Mazzucato M, Cozzi MR, Pradella P, et al. Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow. Blood 2004; 104: 3221-3227.
27. 1-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen. Blood 2002; 100: 2499-2505.
28. Mazzucato M, Pradella P, Cozzi MR, et al. Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Iba mechanoreceptor. Blood 2002; 100: 2793-2800.
29. Dorsam RT, Kim S, Murugappan S, et al. Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways. Blood 2005; 105: 2749-2756.
30. Wunder B, Melzer S. Interlayer vacancy characterization of synthetic phlogopitic micas by IR spectroscopy. Eur J Mineral 2002; 14: 1129-1138.
31. Goto S, Salomon DR, Ikeda Y, et al. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995; 270: 23352-23361.
32. Dachary-Prigent J, Freyssinet JM, Pasquet JM, et al. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-2565.
33. Merten M, Chow T, Hellums TD, et al. A new role for P-selectin in shear-induced platelet aggregation. Circulation 2000; 102: 2045-2050.
34. Richter, H. Rohrhydraulik. Springer-Verlag; 1971.
35. Muggli R, Baumgartner HR, Tschopp TB, et al. Automated microdensitometry and protein assays as a measure for platelet adhesion and aggregation on collagen-coated slides under controlled flow conditions. J Lab Clin Med 1980; 95: 195-207.
36. Brian S. Perry's Chemical Engineer's Handbook. 6th Ed. New York: McGraw-Hill Book Co, 1984; 5: 23-25.
37. Fukuyama M, Sakai K, Itagaki I, et al. Continuous measurement of shear-induced platelet aggregation. Thromb Res 1989; 54: 253-260.
38. Chow TW, Hellums JD, Moake JL, et al. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood 1992; 80: 113-120.
39. Osende JI, Fuster V, Lev EI, et al. Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: Relevance for monitoring long-term glycoprotein IIb/IIIa inhibition. Circulation 2001; 103: 1488-1491.
40. Shenkman B, Schneiderman J, Tamarin I, et al. Testing the effect of GPIIb-IIIa antagonist in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods. Thromb Res 2001; 102: 311-317.
41. Sutera SP, Nowak MD, Joist JH, et al. A programmable, computer-controlled cone-plate viscometer for the application of pulsatile shear stress to platelet suspensions. Biorheology 1988; 25: 449-459.
42. Smoluchowski MV. Versuch einer mathematischen theorie der koagulationskinetik kolloider losungen. Z Phys Chem 1917; 92:129-168.
43. Levich, VG. Physicochemical hydrodynamics. Englewood Cliffs, NJ, Prentice Hall, 1962.
44. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Heart 1991; 66: 351-355.
45. Johansson L, Jansson JH, Boman K, et al. Prospective study on soluble thrombomodulin and von Willebrand factor and the risk of ischemic and hemorrhagic stroke. Thromb Haemost 2002; 87: 211-217.
46. Elena IS, Dmitry AK, Nadezhda YP, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425-434.
47. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-1132.
48. Hsu-Lin S, Berman CL, Furie BC, et al. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets. J Biol Chem 1984; 259: 9121-9126.
49. Belval T, Hellums JD, Solis RT. The kinetics of platelet aggregation induced by fluid-shearing stress. Microvasc Res 1984; 28: 279-288.
50. Belval TK, Hellums JD. Analysis of shear-induced platelet aggregation with population balance mathematics. Biophys J 1986; 50: 479-487.